title: Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C.
authors.forename: Bruno C
authors.initials: BC
authors.lastname: Medeiros
authors.forename: Paul A
authors.initials: PA
authors.lastname: Seligman
authors.forename: Gregory T
authors.initials: GT
authors.lastname: Everson
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Forman
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000139:chemically induced*; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin